Shares of HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) have been given a consensus recommendation of “Buy” by the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, eleven have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $113.31.
A number of research firms recently issued reports on HQY. Mizuho initiated coverage on HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective on the stock. Barrington Research reaffirmed an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a research note on Friday, March 14th. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their target price for the company from $120.00 to $115.00 in a research note on Tuesday. Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. Finally, Royal Bank of Canada increased their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th.
View Our Latest Research Report on HQY
Insider Buying and Selling
Hedge Funds Weigh In On HealthEquity
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Arcadia Investment Management Corp MI bought a new stake in HealthEquity in the fourth quarter worth $26,000. Transce3nd LLC purchased a new position in shares of HealthEquity during the fourth quarter valued at $29,000. Smartleaf Asset Management LLC increased its position in HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after purchasing an additional 98 shares during the period. UMB Bank n.a. lifted its position in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ boosted its position in HealthEquity by 1,934.8% during the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock valued at $45,000 after acquiring an additional 445 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.
HealthEquity Trading Down 0.1 %
Shares of HealthEquity stock opened at $90.19 on Friday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a fifty day simple moving average of $104.40 and a 200 day simple moving average of $95.94. HealthEquity has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a market capitalization of $7.80 billion, a P/E ratio of 82.74, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More
- Five stocks we like better than HealthEquity
- ETF Screener: Uses and Step-by-Step Guide
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- NVIDIA Insiders Sell: This Is What It Means for the Market
- What Are Dividend Contenders? Investing in Dividend Contenders
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.